Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review
Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program sotagliflozin for heart failure and type 1 diabetes. Its clinical and preclinical development programs, LX2761 and LX9211 are focused at treating diabetes and neuropathic pain respectively. Lexicon has a laboratory in Texas. It has business collaborations with several pharmaceutical and biotechnology companies. Lexicon is headquartered at The Woodlands, Texas, the US.
Lexicon Pharmaceuticals Inc Key Recent Developments
Mar 10,2021: Lexicon Pharmaceuticals reports fourth quarter and full-year 2020 financial results and provides clinical update
Mar 04,2021: Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021
Oct 29,2020: Lexicon Pharmaceuticals reports third quarter 2020 financial results and provides clinical update
Jul 30,2020: Lexicon Pharmaceuticals reports second quarter 2020 financial results and provides a business update
Apr 27,2020: Lexicon Pharmaceuticals reports first quarter 2020 financial results and provides a business update
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program sotagliflozin for heart failure and type 1 diabetes. Its clinical and preclinical development programs, LX2761 and LX9211 are focused at treating diabetes and neuropathic pain respectively. Lexicon has a laboratory in Texas. It has business collaborations with several pharmaceutical and biotechnology companies. Lexicon is headquartered at The Woodlands, Texas, the US.
Lexicon Pharmaceuticals Inc Key Recent Developments
Mar 10,2021: Lexicon Pharmaceuticals reports fourth quarter and full-year 2020 financial results and provides clinical update
Mar 04,2021: Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021
Oct 29,2020: Lexicon Pharmaceuticals reports third quarter 2020 financial results and provides clinical update
Jul 30,2020: Lexicon Pharmaceuticals reports second quarter 2020 financial results and provides a business update
Apr 27,2020: Lexicon Pharmaceuticals reports first quarter 2020 financial results and provides a business update
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Lexicon Pharmaceuticals Inc - Key Facts
Lexicon Pharmaceuticals Inc - Key Employees
Lexicon Pharmaceuticals Inc - Key Employee Biographies
Lexicon Pharmaceuticals Inc - Major Products and Services
Lexicon Pharmaceuticals Inc - History
Lexicon Pharmaceuticals Inc - Company Statement
Lexicon Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Lexicon Pharmaceuticals Inc - Business Description
Lexicon Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Lexicon Pharmaceuticals Inc - Strengths
Lexicon Pharmaceuticals Inc - Weaknesses
Lexicon Pharmaceuticals Inc - Opportunities
Lexicon Pharmaceuticals Inc - Threats
Lexicon Pharmaceuticals Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 10, 2021: Lexicon Pharmaceuticals reports fourth quarter and full-year 2020 financial results and provides clinical update
Mar 04, 2021: Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021
Oct 29, 2020: Lexicon Pharmaceuticals reports third quarter 2020 financial results and provides clinical update
Jul 30, 2020: Lexicon Pharmaceuticals reports second quarter 2020 financial results and provides a business update
Apr 27, 2020: Lexicon Pharmaceuticals reports first quarter 2020 financial results and provides a business update
Mar 12, 2020: Lexicon Pharmaceuticals reports fourth quarter and full-year 2019 financial results and provides a business update
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Lexicon Pharmaceuticals Inc - Key Facts
Lexicon Pharmaceuticals Inc - Key Employees
Lexicon Pharmaceuticals Inc - Key Employee Biographies
Lexicon Pharmaceuticals Inc - Major Products and Services
Lexicon Pharmaceuticals Inc - History
Lexicon Pharmaceuticals Inc - Company Statement
Lexicon Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Lexicon Pharmaceuticals Inc - Business Description
Lexicon Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Lexicon Pharmaceuticals Inc - Strengths
Lexicon Pharmaceuticals Inc - Weaknesses
Lexicon Pharmaceuticals Inc - Opportunities
Lexicon Pharmaceuticals Inc - Threats
Lexicon Pharmaceuticals Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 10, 2021: Lexicon Pharmaceuticals reports fourth quarter and full-year 2020 financial results and provides clinical update
Mar 04, 2021: Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021
Oct 29, 2020: Lexicon Pharmaceuticals reports third quarter 2020 financial results and provides clinical update
Jul 30, 2020: Lexicon Pharmaceuticals reports second quarter 2020 financial results and provides a business update
Apr 27, 2020: Lexicon Pharmaceuticals reports first quarter 2020 financial results and provides a business update
Mar 12, 2020: Lexicon Pharmaceuticals reports fourth quarter and full-year 2019 financial results and provides a business update
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Lexicon Pharmaceuticals Inc, Key Facts
Lexicon Pharmaceuticals Inc, Key Employees
Lexicon Pharmaceuticals Inc, Key Employee Biographies
Lexicon Pharmaceuticals Inc, Major Products and Services
Lexicon Pharmaceuticals Inc, History
Lexicon Pharmaceuticals Inc, Subsidiaries
Lexicon Pharmaceuticals Inc, Key Competitors
Lexicon Pharmaceuticals Inc, Ratios based on current share price
Lexicon Pharmaceuticals Inc, Annual Ratios
Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...1)
Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...2)
Lexicon Pharmaceuticals Inc, Interim Ratios
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Lexicon Pharmaceuticals Inc, Key Facts
Lexicon Pharmaceuticals Inc, Key Employees
Lexicon Pharmaceuticals Inc, Key Employee Biographies
Lexicon Pharmaceuticals Inc, Major Products and Services
Lexicon Pharmaceuticals Inc, History
Lexicon Pharmaceuticals Inc, Subsidiaries
Lexicon Pharmaceuticals Inc, Key Competitors
Lexicon Pharmaceuticals Inc, Ratios based on current share price
Lexicon Pharmaceuticals Inc, Annual Ratios
Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...1)
Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...2)
Lexicon Pharmaceuticals Inc, Interim Ratios
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Lexicon Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Lexicon Pharmaceuticals Inc, Ratio Charts
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Performance Chart (2016 - 2020)
Lexicon Pharmaceuticals Inc, Ratio Charts
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021